| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chairman Of Development | Chief Medical Officer
1 company
Yver Antoine is an EVP &Chairman Of Development at Centessa Pharmaceuticals plc. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $31.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | CNTA Centessa Pharmaceuticals Plc | EVP &Chairman Of Development | Sell | 10,423 | $4.45 | $46,405.28 | -1.3% | -11.2% | +65.8% | |
| Jul 18, 2022 | CNTA Centessa Pharmaceuticals Plc | EVP &Chairman Of Development | Sell | 20,000 | $4.87 | $97,312.00 | -2.4% | -24.5% | +52.0% | |
| Jul 1, 2022 | CNTA Centessa Pharmaceuticals Plc | EVP &Chairman Of Development | Sell | 9,100 | $5.03 | $45,796.66 | -1.2% | -17.8% | +19.7% | |
| Jun 17, 2022 | CNTA Centessa Pharmaceuticals Plc | EVP &Chairman Of Development | Sell | 9,200 | $4.68 | $43,035.76 | -1.2% | -3.7% | +15.2% | |
| May 18, 2022 | CNTA Centessa Pharmaceuticals Plc | EVP &Chairman Of Development | Sell | 85,000 | $5.17 | $439,733.76 | -5.2% | -15.2% | -12.9% |